Haleon (HLN) Income from Continuing Operations (2021 - 2023)

Haleon (HLN) posted Income from Continuing Operations of 1521652211.48 for Q4 2023, up 190.91% on a QoQ basis from 523069797.97 in Q2 2023, and up 24.86% year-over-year from 1218672525.66 in Q4 2022.

Haleon (HLN) Income from Continuing Operations (2021 - 2023) Analysis & Trends

Haleon's Income from Continuing Operations history runs 3 years deep, the most recent figure standing at 1521652211.48 for Q4 2023.

  • Quarterly Income from Continuing Operations rose 24.86% year-over-year to 1521652211.48 in Q4 2023, while the trailing twelve-month figure through Dec 2023 was 3926140113.14 (changed N/A YoY) and the FY2025 annual result came in at 2215097364.33, up 17.48% from the prior year.
  • Income from Continuing Operations was 1521652211.48 for Q4 2023 at Haleon, up from 523069797.97 in the prior quarter.
  • Across five years, Income from Continuing Operations topped out at 1675577184.73 in Q4 2021 and bottomed at 523069797.97 in Q2 2023.
  • A 3-year average of 1110926033.36 and a median of 1141255713.97 in 2022 frame the typical range for Income from Continuing Operations.
  • Annual changes were most pronounced in 2022 — Income from Continuing Operations decreased 27.27% — and 2023, when it grew 24.86%.
  • Haleon's Income from Continuing Operations stood at 1675577184.73 in 2021, then declined by 27.27% to 1218672525.66 in 2022, then increased by 24.86% to 1521652211.48 in 2023.
  • Business Quant data shows HLN's Income from Continuing Operations at 1521652211.48 in Q4 2023, 523069797.97 in Q2 2023, and 662745578.03 in Q2 2023.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Income (Continuing) (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn 370.00 Mn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn 601.00 Mn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn -3.58 Bn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn 274.90 Mn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn 176.40 Mn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn 197.90 Mn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn 57.00 Mn
10 Vireo Growth 10.57 Bn 10.41 Bn 59.30 Mn -22.50 Mn

Historic Data

Download Data
DateValue
Dec 31, 2023 1.52 Bn
Jun 30, 2023 523.07 Mn
May 3, 2023 662.75 Mn
Dec 31, 2022 1.22 Bn
Sep 20, 2022 1.06 Bn
Dec 31, 2021 1.68 Bn